The findings, presented at ENDO 2026, the Endocrine Societys annual meeting, showed an increase in hypotensive episodes after patients started GLP-1s
however, we strongly recommend also informing your primary care physician of any new treatments, including compounded peptides
1 2 3 4 "Novo Nordisk prepares new cheaper version of Ozempic as generics face delays"
Semaglutide is a GLP-1 receptor agonist that slows stomach emptying and reduces hunger signals, making it effective for weight loss even in patients with existing thyroid disease
Schedule your complimentary consultation today and learn why patients throughout Martin County, Palm City, Jensen Beach, and the Treasure Coast trust us for their peptide and regenerative medicine needs